March 4, 2024



One Day After White House Signs $3.2 Billion Pfizer Deal, FDA Says Fall COVID Boosters Must Target Omicron Subvariants

The Defender- Children’s Health Defense

By  Megan Redshaw

July 5, 2022

The U.S. Food and Drug Administration (FDA) advised COVID-19 vaccine manufacturers on June 30 that any modifications to booster shots for fall will need to target Omicron subvariants BA.4 and BA.5, which account for more than half of new virus cases in the U.S.

Original vaccines based on the Wuhan strain that is no longer circulating will be used for anyone getting their primary series of shots.

Read more…